J. Pinski et al., EFFECT OF CHRONIC ADMINISTRATION OF A NEW POTENT AGONIST OF GH-RH(1-29)NH2 ON LINEAR GROWTH AND GH RESPONSIVENESS IN RATS, Regulatory peptides, 65(3), 1996, pp. 197-201
The effects of a repeated or continuous administration of a potent ago
nistic analog of growth hormone-releasing hormone (GH-RH), [Dat(1), Th
r(8), Orn(12,21), Abu(15), Nle(27), Asp(28), ASm(29)] hGH-RH(1-29) (JI
-36), on the linear growth and the CH responses to bolus injections of
GH-RH(1-29)NH2 were investigated in male rats about 7 weeks old. Body
weight and tail length were monitored. Basal serum GH and IGF-I conce
ntrations and GH responses to GH-RH(1-29)NH2 were measured by RIA. Chr
onic administration of GH-RH agonist JI-36 by continuous release from
osmotic minipumps at the rate of 0.2 mu g/h or twice daily injections
of 0.5 and 5 mu g/rat for 4 weeks significantly speeded up the growth
of rats as measured by the tail length. The acceleration of growth was
similar in the 3 groups and was associated with stimulation of IGF-I
secretion. The GH response to bolus injection of GH-RH(1-29)NH2 was pr
eserved in all groups and no attentuation of the response occurred in
rats treated for 4 weeks with agonist JI-36 as compared with the contr
ol group. Our results indicate that chronic administration of GH-RH ag
onist JI-36 significantly increases the growth rate without affecting
somatotroph responsiveness in rats. It is therefore likely that this c
lass of GH-RH agonists may be useful clinically.